Cargando…
The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China
BACKGROUND: A nationwide ban on family/replacement donation (FRD) went into effect on April 1, 2018 in China. To date, no reports relevant to the trend of plateletpheresis donations before and after a nationwide ban on FRD were found. METHODS: We used two independent full samples, consisting of 135,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082857/ https://www.ncbi.nlm.nih.gov/pubmed/33926409 http://dx.doi.org/10.1186/s12889-021-10819-4 |
_version_ | 1783685918062804992 |
---|---|
author | Chen, Jinyan Zhou, Guoli Fu, Xuemei Li, Shijie Li, Ying Kang, Jianxun Chen, Huiyou Zhou, Liqiao Fu, Yongshui |
author_facet | Chen, Jinyan Zhou, Guoli Fu, Xuemei Li, Shijie Li, Ying Kang, Jianxun Chen, Huiyou Zhou, Liqiao Fu, Yongshui |
author_sort | Chen, Jinyan |
collection | PubMed |
description | BACKGROUND: A nationwide ban on family/replacement donation (FRD) went into effect on April 1, 2018 in China. To date, no reports relevant to the trend of plateletpheresis donations before and after a nationwide ban on FRD were found. METHODS: We used two independent full samples, consisting of 135,851 and 82,129 plateletpheresis donors from Guangzhou and Chengdu between October 2012 and September 2019, respectively. A pseudo-panel data approach was applied by grouping three time-invariant covariates – gender, blood donation history, and birth year across 14 cross-sections (a 6-month interval each) to form a total of 24 cohort groups (14 × 24 = 336 cohorts, i.e., cells) with each having common covariates. The outcome was average apheresis platelet units per donor in each cell. We performed a two-piecewise linear mixed model with the cross-section (i.e., time) just right before the ban as a time breakpoint (i.e., 11th cross-section) to examine the trend of outcome with the adjustment of three time-invariant covariates. We removed the FRDs in each of the first 11 cross-sections to detect its possible influence on the trend. RESULTS: The final model for the samples from Guangzhou presented a two-piecewise linear trend of the outcome over time with a horizontal line to the left of the breakpoint (β(timeBefore11) = 0.0111, p = 0.0976) and a significantly positive linear trend to the right (β(timeAfter11) = 0.0404, p < 0.0001). The male donors and the donors with plateletpheresis donation history had an increased baseline outcome and a significant outcome change over time after the ban. Such a two-piecewise linear trend pattern can be replicated using the samples from Chengdu with some minor variations. Removing the FRD before the ban can change the pattern. CONCLUSION: The significant increase of the average apheresis platelet units per donor over time after the FRD ban may be related to the implement of the FRD ban and the improved donation behavior of male donors and/or donors with platelet donation history after the ban. Our findings may potentially motivate the policymakers in other countries where the FRD for plateletpheresis donation is still legitimate to phase out their FRD strategy and ultimately achieve 100% voluntary plateletpheresis donation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-10819-4. |
format | Online Article Text |
id | pubmed-8082857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80828572021-04-29 The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China Chen, Jinyan Zhou, Guoli Fu, Xuemei Li, Shijie Li, Ying Kang, Jianxun Chen, Huiyou Zhou, Liqiao Fu, Yongshui BMC Public Health Research BACKGROUND: A nationwide ban on family/replacement donation (FRD) went into effect on April 1, 2018 in China. To date, no reports relevant to the trend of plateletpheresis donations before and after a nationwide ban on FRD were found. METHODS: We used two independent full samples, consisting of 135,851 and 82,129 plateletpheresis donors from Guangzhou and Chengdu between October 2012 and September 2019, respectively. A pseudo-panel data approach was applied by grouping three time-invariant covariates – gender, blood donation history, and birth year across 14 cross-sections (a 6-month interval each) to form a total of 24 cohort groups (14 × 24 = 336 cohorts, i.e., cells) with each having common covariates. The outcome was average apheresis platelet units per donor in each cell. We performed a two-piecewise linear mixed model with the cross-section (i.e., time) just right before the ban as a time breakpoint (i.e., 11th cross-section) to examine the trend of outcome with the adjustment of three time-invariant covariates. We removed the FRDs in each of the first 11 cross-sections to detect its possible influence on the trend. RESULTS: The final model for the samples from Guangzhou presented a two-piecewise linear trend of the outcome over time with a horizontal line to the left of the breakpoint (β(timeBefore11) = 0.0111, p = 0.0976) and a significantly positive linear trend to the right (β(timeAfter11) = 0.0404, p < 0.0001). The male donors and the donors with plateletpheresis donation history had an increased baseline outcome and a significant outcome change over time after the ban. Such a two-piecewise linear trend pattern can be replicated using the samples from Chengdu with some minor variations. Removing the FRD before the ban can change the pattern. CONCLUSION: The significant increase of the average apheresis platelet units per donor over time after the FRD ban may be related to the implement of the FRD ban and the improved donation behavior of male donors and/or donors with platelet donation history after the ban. Our findings may potentially motivate the policymakers in other countries where the FRD for plateletpheresis donation is still legitimate to phase out their FRD strategy and ultimately achieve 100% voluntary plateletpheresis donation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-10819-4. BioMed Central 2021-04-29 /pmc/articles/PMC8082857/ /pubmed/33926409 http://dx.doi.org/10.1186/s12889-021-10819-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Chen, Jinyan Zhou, Guoli Fu, Xuemei Li, Shijie Li, Ying Kang, Jianxun Chen, Huiyou Zhou, Liqiao Fu, Yongshui The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China |
title | The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China |
title_full | The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China |
title_fullStr | The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China |
title_full_unstemmed | The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China |
title_short | The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China |
title_sort | apheresis platelet donation was increased after a nationwide ban on family/replacement donation in china |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082857/ https://www.ncbi.nlm.nih.gov/pubmed/33926409 http://dx.doi.org/10.1186/s12889-021-10819-4 |
work_keys_str_mv | AT chenjinyan theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT zhouguoli theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT fuxuemei theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT lishijie theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT liying theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT kangjianxun theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT chenhuiyou theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT zhouliqiao theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT fuyongshui theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT chenjinyan apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT zhouguoli apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT fuxuemei apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT lishijie apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT liying apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT kangjianxun apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT chenhuiyou apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT zhouliqiao apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina AT fuyongshui apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina |